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1. Introduction 
The inhibition of protein synthesis in auxotrophic 
RCSf (rel’) bacteria by starvation in one essential 
amino acid or by impairment of aminoacyl-tRNA 
synthetase activity, leads to a halt of net RNA 
synthesis [l-5] and to a large increase in pp5’G2’ 
(3’) pp synthesis formation [6-81. 
None of these phenomena are observed in R@ 
(ref-) mutants [6, 7,9]. The link between the altera- 
tion of some specific step(s) of protein synthesis and 
the control of RNA synthesis is very likely ppGpp as 
suggested by Cashel [7]. Thus, it seemed appropriate 
to evaluate the concentration of ppGpp in conditions 
where the balance between protein and RNA synthe- 
sis had been disrupted by levallorphan. Levallorphan 
is a morphinane derivative, which reduces the growth 
rate of E. coli, causes an immediate inhibition of 
ribosomal RNA synthesis while affecting protein 
synthesis much less [ 10, II]. The present report 
indicates that the transitory RNA synthesis inhibi- 
tion induced by levallorphan is accompanied by an 
over-production of ppGpp in rel’ but not in rel- 
alleles. 
2. Materials and methods 
The phototrophic E. coli K1 z SF- and the follow- 
ing mutants: 15 TAU (thy ; arg; ura; reZ’), l_S.TAU 
(thy; urg; ura; rel-); CP 78 (his; arg; thr:‘, iaC’< 
B, ; rel’) and CP 79 (his ; arg; thr ; leu ; B, ; rel-) 
North-Holland Publishing Company - Amsterdam 
were grown in the medium previously described [lo] 
and modified to reduce phosphate concentration to 
2.5 X low4 M. Glucose or succinate were the carbon 
sources. The synthesis of RNA was followed by incor- 
poration of 3 H-uracil in the material insoluble in cold 
1 M formic acid. ppGpp was labelled, isolated and 
measured as described by Cashel [6, 71 . 
3. Results 
The concentration of ppGpp increased in ref’ but 
not in rel- mutant after levallorphan addition (fig. 1) 
Similar results were observed on the CP 78/CP79 
allelic pair. In all cases. however, Levallorphan did 
affect the growth rate of rel’ and rel- mutants by the 
same factor. 
For comparison the influence of levallorphan on 
ppGpp and RNA synthesis in the photorrophic strain 
K, z S growing on glucose mineral medium is shown 
in fig. 2. The growth rate was permanently reduced 
by 60% while the synthesis of RNA first inhibited by 
90% progressively accelerated to fit the requirements 
of the new growth rate. ppCpp synthesis was transien- 
tly enhanced. Chloromycetin (100 /&ml), when added 
15 min after levallorphan, caused an immediate fall in 
the level of ppGpp and stimulated the accumulation 
of large amounts of RNA. 
Thus, the pattern of RNA synthesis after levallor- 
phan addition (i.e.: a transitory and selective inhibi- 
tion of ribosomal RNA synthesis) clearly resembles 
that observed after a shift from a rich to a poor me- 
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Fig. 1. Concentrations of ppGpp in rel+ and rel-E. coli 15 TAU 
after levallorphan addition. E. coli 15 TAU (reZ+) (+-c) and 
15 TAU (rel-) (-) were grown exponentially in a glucose 
minimal medium and received 32Pi (20 &i/ml) at time zero. 
After 90 min levallorphan 1.5 mM was added (arrow). In both 
cases the growth rate was reduced from 0.95 to 0.25 g/hr. 
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Fig. 2. Influence of levallorphan on ppGpp and RNA synthesis 
in E. co/i K12S. A culture of E. coli KlzS F-in glucose mine- 
ral medium was split in two parts. One part received 32Pi 
(18 &i/ml) and the other 3H-uracil (20 &ml). Levallorphan 
1.2 mM was added (L) after 45 min in both parts. 15 min later, 
chloramphenicol (CM) (100 pg/ml) was added to half of each 
part (e----o, A----A). The growth rates were 0.42 g/hr without 
and 0.20 g/hr with tevallorphan added. (A) ppGpp concentra- 
tions; (B) uptake of 3H-uracil. 
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Fig. 3. Over production of ppGpp after a carbon source in- 
duced down shift. A culture of E, coli K12S F-in a glucose- 
mineral medium (p = 0.42 g/hr) received 32Pi (18 &i/ml) at 
time zero. 45 min later the bacteria were filtered and resus- 
pended in the succinate-mineral medium containing also 
32 Pi (18 &i/ml). 
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Fig; 4. Influence of levallorphan on the uptake of uracil in 
rel and rel-bacteria. 3H-uracil (20 q/ml) was added to log 
phase cultures of E. coli 15 TAU (rel ) and 15 TAU (rel-) 
in glucose minimal medium. Levallorphan 1.2 mM was added 
(L) after 40 min (M, .1--d). After 60 min half of each 
culture received 100 pg/ml chloromycetin (CM) (*----0, 
A----A). As control, a part of the rel-culture was filtered at 
40 min and resuspended in arginine free medium (O----Z). 
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dium. The fact that the level of ppGpp was simulta- 
neously enhanced suggests that the product of the 
RC locus is normally involved in this type of regula- 
tion. A very similar response of ppGpp synthesis was 
observed in the same prototrophic strain after a shift- 
down involving the carbon source (fig. 3). The final 
growth rate, in this case, was about the same as after 
the addition of 1.5 mmole/ 1 of levallorphan in the 
glucose-containing medium (i.e. conditions of the 
experiments of fig. 2). 
If the transitory inhibition of rRNA synthesis 
induced by levallorphan is directly connected to the 
extra-synthesis of ppGpp, one can postulate that 
bacteria bearing the rel- allele should be unable to 
regulate specifically RNA synthesis after levallorphan 
addition. Comparison of RNA synthesis in rel’ and 
rel-pairs supports this contention (fig. 4). 
In the rel- mutant, the synthesis of RNA was not 
inhibited more than the rate of growth, and did not 
respond to the addition of chloromycetin. As control, 
the removal of arginine yielded a lower initial rate of 
RNA synthesis. 
4. Discussion 
Since the growth rate of the rel’ and rel- allelic 
strains tested is equally sensitive to levallorphan, 
whereas RNA synthesis is specifically depressed in 
rel’ mutants, it appears that the primary site of ac- 
tion of levallorphan is not RNA synthesis itself. 
This specific and transitory RNA inhibition associat- 
ed with an increased ppGpp synthesis suggests that 
levallorphan triggers a regulation process mediated 
by the product of the RC gene. 
From a number of experiments, it is more likely 
that levallorphan acts at the level of the bacterial 
membrane [ 12- 161, Morphinane derivatives were 
shown by Gale et al. [ 171 and Simon et al. [ 181 to 
alter the permeation of some amino acids. The limi- 
tation of amino acid availability inside the cell could 
explain: i) the limitation of the growth rate of auxo- 
trophic strains of E. coli in an amino acid containing 
medium; and ii) the shift down pattern and the ppGpp 
overproduction observed. However, reducing the 
growth rate of a prototrophic strain in a medium 
devoid of amino acids either by levallorphan addi- 
tion or by changing the carbon source raised the level 
of ppGpp in both cases. This could support the inter- 
pretation either that both treatments induce a leakage 
of endogenous amino acids or that the regulatory 
function of the RC gene can be triggered in several 
ways. 
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